Risk-adapted postremission therapy in acute myeloid leukemia: results of the german multicenter AML HD93 treatment trial - Concepedia

Concepedia

Publication | Closed Access

Risk-adapted postremission therapy in acute myeloid leukemia: results of the german multicenter AML HD93 treatment trial

121

Citations

48

References

2003

Year

Richard F. Schlenk, Axel Benner, Frank Hartmann, F. del Valle, Christian Weber, H. Pralle, J. Th. Fischer, U. Gunzer, Antonio Pezzutto, William P. Weber,

Hematological MalignancyRisk-adapted Postremission TherapyOncologyMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaHematologyClinical TrialsMyeloid NeoplasiaMedicineRadiation OncologyHealth Sciences

References

	Year	Citations

Page 1

Page 1